Silybin meglumine, a water‐soluble form of silymarin that can prevent EGFR mutated NSCLC cell EMT, can also prevent the regeneration of tumors that do not respond to gefitinib, thus preventing severe tumor growth.280. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.